We include in our watchlist the ETF SPDR XPH which replicates the S&P 500 Pharmaceutical Index, and is composed mainly of 41 specialty pharmaceutical stocks. This ETF expenses reach 0.35% with a liquidity of $44m and appears to be an attractive short-term trading opportunity.
The long-term chart seems ready for a change in trend, which is reflected in a bullish crossover of the MACD as the prices approach the EMA26. A breakout of the 44/45 $ zone would be a significant positive factor.
XPH : monthly data
The weekly chart is improving strongly, through the ascending moving averages and the bullish MACD. It remains an important step to cross : the M100 located at 44.3 $.
Once this area is crossed, the trend would clearly become bullish.
XPH : weekly data
Retrouvez-nous désormais sur https://phi-advisor.com/fr/
pour bénéficier de nos signaux d’achat et de vente de plus de 300 ETFs !
Nous utilisons des cookies pour vous garantir la meilleure expérience sur notre site. Si vous continuez à utiliser ce dernier, nous considérerons que vous acceptez l'utilisation des cookies.Ok
We include in our watchlist the ETF SPDR XPH which replicates the S&P 500 Pharmaceutical Index, and is composed mainly of 41 specialty pharmaceutical stocks. This ETF expenses reach 0.35% with a liquidity of $44m and appears to be an attractive short-term trading opportunity. The long-term chart seems ready for a change in trend, which is reflected in a bullish crossover of the MACD as the prices approach the EMA26. A breakout of the 44/45 $ zone would be a significant positive factor.
XPH : monthly data
The weekly chart is improving strongly, through the ascending moving averages and the bullish MACD. It remains an important step to cross : the M100 located at 44.3 $.
Once this area is crossed, the trend would clearly become bullish.
XPH : weekly data